JA2 WP5 – Applying the HTA Core Model for Rapid Assessment for national adaptation and reporting

Objectives

• To test the capacity of national HTA bodies to produce structured core HTA information (full core/rapid HTAs) together and apply it in national context (including collection of data on costs and overall efficiency of the production in the network)
• To implement, pilot and further develop models and tools as well as production processes to support collaborative production of core HTA information with reinforced secretariat and coordination function
• To develop and test a methodological basis for European cooperation on HTA including guidelines for distinct methodological issues and quality improvement of evidence generation for HTA.

Deliverables

• Pilot rapid assessments

Milestone

• Coordinating and supporting the joint pilots of rapid assessments of pharmaceuticals (strand A) and non-pharmaceuticals (strand B), on a quarterly basis during the first year
• Final rapid model for relative effectiveness of pharmaceuticals and rapid core model for non-pharmaceutical interventions (in cooperation with WP7).

Partners

Lead Partner

ZIN

National Health Care Institute
(Zorginstituut Nederland)

Eekholt 4

NL-112XH Diemen

Netherlands

Telephone: +31 207979057

Fax: +31 (020) 797 8500

http://www.zorginstituutnederland.nl/

Co-Lead Partner

LBI

Associated Partners

Collaborating partners

UCSC GEMELLI, AETSA, AQuAS, AVALIA-T, CHIF, CMSS, Danube University Krems, DGFPS MSPSI, HIS, RIZIV-INAMI, KDTD, KORA, Medical Valley – EMN, MU Sofia, NC HTA, NCPE, NCPRMP, Osteba, SAGEM, SESCS, SMCA, SNHTA, TÜBİTAK-TÜSSİDE<